Call for Papers
(Specific to Therapeutic Disease)
Molecular Mechanisms of Neurodegeneration in Parkinson's Disease
Authors Guide:
Jean-Francois Trempe (McGill Biochemistry) and Kalle Gehring (McGill Biochemistry) are organizing a special issue on "Molecular Mechanisms of Neurodegeneration in Parkinson's Disease" in collaboration with the Journal of Molecular Biology.
Submission:
Original scientific research papers are published in the journal, describing a substantial development in the area and offering mechanistic and functional insights.
Therapeutic disease:
Parkinson's disease is characterized by a wide range of non-motor symptoms and motor abnormalities. The loss of certain brain neurons is the cause of these symptoms. Even though some of these symptoms are treatable, no disease-modifying treatments exist to stop neurodegeneration. Studies on pathophysiology and genetics have shed important light on the possible cause(s) of neurodegeneration, and these, in turn, have stimulated fascinating new research into the molecular mechanisms underlying neurodegenerative diseases. We aim to provide a thorough review of the molecular processes behind the pathways in this special issue, ranging from alpha-synuclein propagation to mitochondrial quality and endolysosomal pathway impairment.
Pubrica Offers:
Pubrica offers you complete publishing support across a variety of publications, journals, and books. We provide complete support from translating your concept to an incisive report, and we will be with you through the entire publication stages. We assist medical doctors, students, hospitals, and pharma and device manufacturers in their quest for a credible writing partner. We have experts across subjects such as life science, medical and technology. Due to our consistent, high-quality writing, we can publish in journals with high-impact factors, including The Lancet Neurology, Acta Neuropathologica, Brain, Alzheimer's and Dementia, JAMA Neurology, Neuro-Oncology, Movement Disorders, etc.
